Insights

The UK’s prevention agenda is accelerating – but will only succeed when diagnostics become more connected, more predictable and easier to access. In a system grappling with workforce pressures, rising chronic disease and inequalities, early detection can no longer rely on fragmented workflows and disconnected systems. It requires an end-to-end diagnostic infrastructure. RDi combines clinically […]

Remote and self‑sampling are essential to expanding access to diagnostics, reducing bottlenecks, and delivering faster answers for healthcare teams and patients. At RDi, we designed our approach around data and automation. We let data drive everything we do, and then we automate for repeatable quality at scale. Here’s how. What data‑driven really means Every kit

The NHS is undergoing its most ambitious transformation in a generation. The new Medium Term Planning Framework sets a clear direction: move away from reactive, hospital-based care and embrace a digital-first, neighbourhood-based model focused on prevention, early diagnosis, and patient empowerment. For RDi, this isn’t just a roadmap, it’s a call to accelerate, partner and deliver. Here’s

April marks Bowel Cancer Awareness Month, a time to shine the light on the fourth most common cancer in the UK. Although bowel cancer affects thousands of people each and every year across the world, there are still so many myths surrounding it, preventing individuals from seeking early detection and consequentially, a timely treatment. In

London, UK, 8th April 2025, LDC-backed RDi, a leader in data-driven, automated self-sampling kits for healthcare, is pleased to announce the successful acquisition of Inicio Health, a pioneering force in healthcare interoperability, automation and AI solutions. This pivotal acquisition unites two forward-thinking companies with a shared mission of delivering smarter, more accessible people-centric pathways for

The theme of this year’s World Cancer Day is ‘united by unique’. This movement is a step in the right direction towards championing people-centred cancer care, and RDi are passionate about being part of thisself- cause. On average, someone is diagnosed with cancer at least every 90 seconds in the UK. In 2024, the number

Worldwide, 30,000 clinical trials are taking place, with 7,000 of those in Phase III. Spending on clinical trials is also estimated to reach $68.9 billion a year by 2025. Clinical trials are undoubtedly essential for healthcare advancement, patient safety and effective treatment. As the industry is continuously evolving, clinical trial industry trends have seen forward-thinking companies stay

In the ever changing landscape of the healthcare sector, we are seeing some big changes taking place, such as the integration of AI, a focus on diversity in clinical trials and the rise of digital healthcare and at-home diagnostics to name a few. Most advancements can be linked to the growth of decentralised clinical trials.

When it comes to biological logistics, particularly the handling and transporting of biological specimens, we rely on our own set of principles: the three Rs of biological sample packaging. Similarly to the three fundamental Rs of basic school skills in our early education; reading, writing and arithmetic’s. These skills have followed us throughout adulthood, building

Did you know that 5 million tonnes of plastic waste comes from hospitals worldwide every year? The NHS alone produces 133,000 tonnes of plastic annually, and only 5% of this is recyclable! The government goal to achieve zero avoidable plastic waste by 2042 coincides with making sure that resources are used more efficiently and kept

LONDON – June 25 2024 – RDi, the leading provider of healthcare and pharma services solutions for patient sample collection, today announced the appointment of David Cahill as Chief Executive Officer. David will lead the business as it builds upon its growing footprint in the healthcare market as the leading supplier of screening, diagnostic and